Ensign Peak Advisors’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$109K Hold
9,177
﹤0.01% 1546
2025
Q4
$91.4K Sell
9,177
-20,750
-69% -$198K ﹤0.01% 1593
2025
Q3
$268K Sell
29,927
-11,200
-27% -$104K ﹤0.01% 1597
2025
Q2
$388K Sell
41,127
-8,100
-16% -$71.5K ﹤0.01% 1616
2025
Q1
$534K Hold
49,227
﹤0.01% 1532
2024
Q4
$469K Hold
49,227
﹤0.01% 1617
2024
Q3
$553K Hold
49,227
﹤0.01% 1579
2024
Q2
$492K Hold
49,227
﹤0.01% 1603
2024
Q1
$567K Sell
49,227
-2,483
-5% -$21.1K ﹤0.01% 1594
2023
Q4
$377K Buy
51,710
+17,500
+51% +$138K ﹤0.01% 1691
2023
Q3
$311K Hold
34,210
﹤0.01% 1684
2023
Q2
$416K Hold
34,210
﹤0.01% 1669
2023
Q1
$425K Buy
34,210
+2,550
+8% +$46.9K ﹤0.01% 1674
2022
Q4
$609K Buy
31,660
+14,950
+89% +$316K ﹤0.01% 1549
2022
Q3
$314K Buy
16,710
+4,360
+35% +$89.6K ﹤0.01% 1687
2022
Q2
$223K Hold
12,350
﹤0.01% 1760
2022
Q1
$198K Hold
12,350
﹤0.01% 1879
2021
Q4
$302K Buy
+12,350
New +$290K ﹤0.01% 1811

Other funds holding AHCO

Ensign Peak Advisors's AHCO Position: Q1 2026 in Review

Ensign Peak Advisors held its AdaptHealth (AHCO) position steady in Q1 2026 at 9,177 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #1546.

Ensign Peak Advisors first reported a position in AHCO in Q4 2021 and has held it in 18 quarters since. The position peaked at $609K in Q4 2022. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Ensign Peak Advisors held 9,177 shares of AdaptHealth worth $109K as of Q1 2026.
  • Ensign Peak Advisors left its AdaptHealth share count unchanged in Q1 2026.
  • AdaptHealth made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q1 2026, its #1546 holding.
  • Ensign Peak Advisors first reported a position in AdaptHealth in Q4 2021 and has held it in 18 quarters since.
  • Ensign Peak Advisors's AdaptHealth position peaked at $609K in Q4 2022.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.